What is the future of personalized medicine? Featuring Dr. Trevor Hawkins (An Introduction to Companion Diagnostics), Dr. Patrick Joseph (Making It Personal for Patients), and Dr. Richard Frank (The Impact on Healthcare Policy), this lively panel discussion will highlight the many ways in which Companion Diagnostics are changing the face of healthcare.
As a patient-centric shift continues to sweep our healthcare system, pharmaceutical companies are increasingly seeing the value of targeting treatments to specific patient populations, making their therapies more personal. In the burgeoning age of personalized medicine, companies are looking for ways to develop more specific, efficacious, and cost-effective treatments that are tailored to a patients needs, rather than focusing solely on the blockbuster drugs that have dominated the industry over the past few decades. Some companies have found novel ways to accommodate this shift, including adjusting their business models to focus on healthcare outcomes and collaborating with payers and providers to simplify reimbursement and provide tools and technologies to increase medication adherence.
Join Drs. Hawkins, Joseph, and Frank and learn how companion diagnostics promises to change the way patients are treated, therapies may be prescribed, and tests are developed, and how this fast-moving evolution will impact all of healthcare.
At the end of the presentation, attendees will be able to: